EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitUmbrella ReviewOpen Access · CC BY 4.0

Umbrella review of mesenchymal stem cell-derived extracellular vesicles in preclinical models: therapeutic efficacy across diverse conditions

Nadiar M Mussin, Kulyash R Zhilisbayeva, Akmaral Baspakova, Madina A Kurmanalina, Amin Tamadon

Frontiers in Cell and Developmental Biology · 13.10.2025 · 13

DOI: 10.3389/fcell.2025.1655623 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 13.10.2025. Verfasst von Nadiar M Mussin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery No. 2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising cell-free therapeutic strategy for various diseases due to their anti-inflammatory, anti-apoptotic, and regenerative properties. Numerous meta-analyses have evaluated MSC-EV efficacy in preclinical animal models, but a comprehensive synthesis across diverse conditions is lacking.

Objective

This umbrella review aims to systematically evaluate the therapeutic efficacy, mechanisms, and methodological quality of MSC-EVs in preclinical models across multiple diseases.

Methods

A systematic search of Scopus and Web of Science was conducted to identify meta-analyses published up to July 2025, focusing on MSC-EV interventions in preclinical animal models. Data were extracted on study characteristics, exosome sources, animal models, outcomes, and risk of bias. The AMSTAR 2 tool assessed meta-analysis quality, while SYRCLE and CAMARADES tools evaluated primary study bias. Narrative and quantitative syntheses summarized efficacy, heterogeneity, and publication bias.

Results

Forty-seven meta-analyses covering 27 diseases were included, spanning neurological, renal, wound healing, liver, musculoskeletal, respiratory, and reproductive disorders. MSC-EVs demonstrated high efficacy, significantly improving functional scores, reducing inflammation, and promoting regeneration. Bone marrow-, adipose-, and umbilical cord-derived EVs were most effective, with modified EVs showing enhanced outcomes. Methodological quality was moderate (AMSTAR 2), with high heterogeneity (I 2 > 70%) and frequent risk of bias due to poor randomization and blinding. Publication bias was noted but often robust after adjustments.

Conclusion

MSC-EVs exhibit robust therapeutic potential across diverse preclinical models, supporting their development as a versatile regenerative therapy. Standardization of EV protocols, improved study quality, and mechanistic insights are critical for clinical translation. This review provides a comprehensive framework for advancing MSC-EV research and application.

Schlagwörter

Stichwörter der Autor:innen

exosomesextracellular vesiclesmesenchymal stem cellspreclinical modelsregenerative medicineumbrella review

Autor:innen und Institutionen

  • Department of General Surgery No. 2, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.
  • Department of Languages, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.
  • Department of Epidemiology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.
  • Department of Dental Disciplines and Maxillofacial Surgery, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.
  • Department of Natural Sciences, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.

Zitieren

APA

Mussin, N. M., Zhilisbayeva, K. R., Baspakova, A., Kurmanalina, M. A., & Tamadon, A. (2025). Umbrella review of mesenchymal stem cell-derived extracellular vesicles in preclinical models: therapeutic efficacy across diverse conditions. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1655623

Vancouver

Mussin NM, Zhilisbayeva KR, Baspakova A, Kurmanalina MA, Tamadon A. Umbrella review of mesenchymal stem cell-derived extracellular vesicles in preclinical models: therapeutic efficacy across diverse conditions. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1655623

BibTeX
@article{Mussin2025,
  author = {Mussin, Nadiar M and Zhilisbayeva, Kulyash R and Baspakova, Akmaral and Kurmanalina, Madina A and Tamadon, Amin},
  title = {Umbrella review of mesenchymal stem cell-derived extracellular vesicles in preclinical models: therapeutic efficacy across diverse conditions},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1655623}
}
Kostenlos starten →